Findings to be presented September 30, 2021
at 90th Annual Meeting of the American Thyroid Association (ATA)
On 30 September 2021, Dr. Roberto Valcavi and Dr. Roberto Novizio will communicate to the 90th ATA congress the results of a study that demonstrated, on a series of 354 patients, that the side effects of radiofrequency thyroid ablation (RFA) are drastically reduced if the intervention is conducted in the operating room rather than in an outpatient setting. The ATA Congress annually presents the latest updates in thyroid disease research and therapy.
RFA thyroid ablation surgery is establishing itself all over the world as a conservative operative alternative to traditional surgery to remove a thyroid lobe or the entire thyroid (thyroid lobectomy and total thyroidectomy) for the treatment of benign thyroid nodules and papillary microtumors malignant thyroid glands. Under ultrasound guidance, a needle electrode is introduced into the thyroid nodule through the skin of the neck. With delicate movements the operator, assisted by a specialized team, uses the radiofrequency device to destroy the nodule. The operation takes place in day surgery and the patient is discharged the same day.
Side effects of thyroid RFA include bleeding, bruising, tumor rupture, and dysphonia (reduced voice) from damage to the lower laryngeal nerve that moves the vocal cord. The sterile environment, the highly specialized staff, the use of the most up-to-date technologies adopted in the surgical room of the ETC Clinic almost totally prevent the side effects of thyroid RFA surgery.